For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...
A bandage hiding a vicious scar from delicate cancer surgery provided a grim sign that feeble former President Joe Biden is ...
The median follow-up of 37 months showed that PSMAiSRT improved FFS and eugonadal FFS, with significant improvements in the ...
HealthDay on MSN
American Society for Radiation Oncology, Sept. 27-Oct. 1
The annual meeting of the American Society for Radiation Oncology was held from Sept. 27 to Oct. 1 in San Francisco, drawing ...
Joe Biden faces mounting medical costs amid cancer treatment, sparking speculation over his finances despite pension income ...
New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...
Ultrasound has long been used for helping doctors see inside the body, but focused high frequency sound waves are offering ...
Michael Dooley thought he was a goner. Diagnosed with advanced pancreas cancer that had spread around his body, the ...
Stocktwits on MSN
Lantheus Holdings Stock Sparks Retail Buzz After Goldman Downgrade; Traders Eye Buying Chance
Lantheus Holdings was among the top 10 trending stocks on Stocktwits on Thursday after Goldman Sachs downgraded the biotech ...
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSION The Summit theme “unlocking the $1 Trillion Wealth ...
An engineered CD40 antibody that can bind to a specific immune receptor and directly injected into tumors has demonstrated in a phase 1 trial that it can trigger a systemic immune response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results